Koki Ito

1.7k total citations
65 papers, 1.2k citations indexed

About

Koki Ito is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Koki Ito has authored 65 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 15 papers in Psychiatry and Mental health. Recurrent topics in Koki Ito's work include Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Schizophrenia research and treatment (11 papers). Koki Ito is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Schizophrenia research and treatment (11 papers). Koki Ito collaborates with scholars based in Japan, United States and Australia. Koki Ito's co-authors include Tsukasa Koyama, Tomohiro Abekawa, Shin Nakagawa, Yasuya Nakato, Yuji Kitaichi, Ichiro Kusumi, Chong Chen, Ichiro Kusumi, Kazunori Uemura and Svend Strandgaard and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Koki Ito

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koki Ito Japan 19 411 396 195 170 139 65 1.2k
Branimir Jernej Croatia 19 504 1.2× 318 0.8× 235 1.2× 191 1.1× 149 1.1× 47 1.1k
Sumio Murase Japan 19 655 1.6× 465 1.2× 137 0.7× 290 1.7× 77 0.6× 41 1.6k
Yung-yu Huang United States 14 569 1.4× 480 1.2× 276 1.4× 163 1.0× 237 1.7× 21 1.6k
Sylvia S. White United States 17 499 1.2× 273 0.7× 137 0.7× 173 1.0× 60 0.4× 28 1.0k
Gaurav Kumar United States 22 511 1.2× 758 1.9× 420 2.2× 201 1.2× 161 1.2× 39 1.7k
Jens‐Uwe Peter Germany 6 618 1.5× 515 1.3× 199 1.0× 87 0.5× 253 1.8× 11 1.8k
A‐Min Huang Taiwan 16 408 1.0× 253 0.6× 117 0.6× 167 1.0× 92 0.7× 20 1.0k
Yingjun Zheng China 22 275 0.7× 342 0.9× 381 2.0× 319 1.9× 312 2.2× 79 1.6k
Hiroyasu Shiraishi Japan 18 363 0.9× 320 0.8× 180 0.9× 144 0.8× 78 0.6× 71 1.0k
Lipa Čičin‐Šain Croatia 19 362 0.9× 259 0.7× 116 0.6× 73 0.4× 106 0.8× 58 838

Countries citing papers authored by Koki Ito

Since Specialization
Citations

This map shows the geographic impact of Koki Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koki Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koki Ito more than expected).

Fields of papers citing papers by Koki Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koki Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koki Ito. The network helps show where Koki Ito may publish in the future.

Co-authorship network of co-authors of Koki Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Koki Ito. A scholar is included among the top collaborators of Koki Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koki Ito. Koki Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Koki, Jin Nakazato, Romain Fontugne, Manabu Tsukada, & Hiroshi Esaki. (2025). A multipath redundancy communication framework for enhancing 5G mobile communication quality. Computer Communications. 239. 108157–108157.
2.
Kushibiki, Toshihiro, Koki Ito, Yoshiki Kato, et al.. (2024). Fatal C-reactive Protein-less Sepsis with Anti-IL-6 Autoantibody Production after Administration of Durvalumab. Internal Medicine. 64(14). 2213–2217.
3.
4.
Ito, Koki, Kyoichi Kaira, Ou Yamaguchi, et al.. (2024). Clinical impact of inflammatory and nutrition index based on metabolic tumor activity in non‑small cell lung cancer treated with immunotherapy. Oncology Letters. 27(3). 110–110. 4 indexed citations
5.
Ito, Koki, et al.. (2024). Severe Atelectasis due to Aspirated Valproic Acid Tablet. SHILAP Revista de lepidopterología. 2024. 1–4. 1 indexed citations
6.
Iizuka, Ai, et al.. (2024). “GO” to move toward dementia‐friendly communities: A pilot study. Brain and Behavior. 14(6). e3581–e3581. 1 indexed citations
7.
Watanabe, Chie, Ryohei Suematsu, Tomoya Sano, et al.. (2023). Longitudinal changes in radiographic features of pulmonary Mycobacterium avium complex diseases. Heliyon. 9(8). e18967–e18967. 4 indexed citations
8.
Zhu, Xiaolei, Shinji Sakamoto, Chiharu Ishii, et al.. (2023). Dectin-1 signaling on colonic γδ T cells promotes psychosocial stress responses. Nature Immunology. 24(4). 625–636. 58 indexed citations
9.
Kimizuka, Yoshifumi, Yoshiki Kato, Koki Ito, et al.. (2023). IgG4‐related retroperitoneal fibrosis induced by nivolumab and ipilimumab in a patient with non‐small cell lung cancer: A case report. Thoracic Cancer. 15(1). 104–107. 5 indexed citations
10.
Kimizuka, Yoshifumi, Hiraku Ogata, Koki Ito, et al.. (2022). Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome: A case report. Journal of Infection and Chemotherapy. 28(11). 1562–1566. 1 indexed citations
11.
Hashimoto, Naoki, Daisuke Fujisawa, Atsuo Nakagawa, et al.. (2020). A pilot validation study of the Japanese translation of the Positive and Negative Syndrome Scale (PANSS). Asian Journal of Psychiatry. 54. 102210–102210. 6 indexed citations
12.
Hashimoto, Naoki, Atsuhito Toyomaki, Ryo Okubo, et al.. (2019). <p>Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)</p>. Neuropsychiatric Disease and Treatment. Volume 15. 3511–3518. 13 indexed citations
13.
Chen, Chong, et al.. (2016). The exercise-glucocorticoid paradox: How exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels. Frontiers in Neuroendocrinology. 44. 83–102. 148 indexed citations
14.
Saito, Atsushi, Bagrat Abazyan, Yu Taniguchi, et al.. (2015). Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory. Neurobiology of Disease. 82. 176–184. 32 indexed citations
15.
Asakura, Satoshi, Takeshi Inoue, Nobuki Kitagawa, et al.. (2012). Social Anxiety/Taijin-Kyofu Scale (SATS): Development and Psychometric Evaluation of a New Instrument. Psychopathology. 45(2). 96–101. 7 indexed citations
16.
Nakato, Yasuya, Tomohiro Abekawa, Koki Ito, Takeshi Inoue, & Tsukasa Koyama. (2010). Lamotrigine blocks apoptosis induced by repeated administration of high-dose methamphetamine in the medial prefrontal cortex of rats. Neuroscience Letters. 490(3). 161–164. 10 indexed citations
17.
Putti, Thomas Choudary, et al.. (2008). Inactivation of RUNX3 by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression. Modern Pathology. 21. 5 indexed citations
18.
19.
Kusumi, Ichiro, et al.. (2007). Tone duration mismatch negativity deficits predict impairment of executive function in schizophrenia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(1). 95–99. 63 indexed citations
20.
Ito, Koki, et al.. (1993). [Drug induced hemolytic uremic syndrome].. PubMed. 51(1). 204–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Branimir Jernej Breakdown of academic impact, for papers by Sumio Murase Breakdown of academic impact, for papers by Yung-yu Huang Breakdown of academic impact, for papers by Sylvia S. White Breakdown of academic impact, for papers by Gaurav Kumar Breakdown of academic impact, for papers by Jens‐Uwe Peter Breakdown of academic impact, for papers by A‐Min Huang Breakdown of academic impact, for papers by Yingjun Zheng Breakdown of academic impact, for papers by Hiroyasu Shiraishi Breakdown of academic impact, for papers by Lipa Čičin‐Šain
Rankless by CCL
2026